Product performance test for medicated chewing gums

Pharmacopeial Forum

Volumn 34, Issue 3, 2008, Pages 843-847

  Gajendran, Jayachandar ^a,c   Kraemer, Johannes ^a,d   Knudsen, Stig Randers ^b,d   Brown, Will ^e  

^a PHAST   (Germany)

^b Fertin Pharma AS   (Denmark)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d The USP Mucosal Drug Delivery Advisory Committee ^*

^e UNITED STATES PHARMACOPEIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIVE AGENT;

ARTICLE; CHEWABLE TABLET; CHEWING GUM; DRUG DOSAGE FORM; DRUG MARKETING; DRUG QUALITY; DRUG RELEASE; MASTICATION; MEDICAL LITERATURE; MOUTH CAVITY; QUALITY CONTROL; TABLET FORMULATION; UNITED STATES;

EID: 44849110483     PISSN: 03634655     EISSN: 15421945     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Committee for Medicinal Products for Human Use. CPMP list of allowed terms for the pharmaceutical dosage form, route of administration, container, closure and administration devices. Brussels, Belgium; 1991:III/3593/91.
2. Shah VP, Derdzinski K, Ewing G, et al. A performance test for topical and transdermal dosage Forms. Pharm Forum. 2006;32(5):1586-1589.
3. Shah VP, Ueda CT. USP Advisory Panel on the USP Performance Test for Topical and Transdermal Dosage Forms. Pharm Forum. 2006;32(5):1584-1585.
4. United States Pharmacopeial Convention. USP 30-NF 25. Rockville, MD; United States Pharmacopeial Convention; 2007:2750-2751.
5. United States Phannacopeial Convention. USP 30-NF 25. United States Pharmacopeial Convention. Rockville, MD; United States Pharmacopeial Convention, 2007:2751.
6. European Directorate for the Quajity of Medicines, Council of Europe. European Pharmacopoeia. General Monograph on Dosage Forms: Chewing Gums, Medicated. 5th Edition. Strasbourg, France; European Directorate for the Quality of Medicines, Council of Europe; 2005:601.
7. European Directorate for the Quality of Medicines, Council of Europe. European Pharmacopoeia. General Monograph on Dosage Forms. Chewing Gums, Medicated. 6th Ed. Strasbourg, France; European Directorate fdr the Quality of Medicines, Council of Europe; 2008:719.
8. European Directorate for the Quality of Medicines, Council of Europe, European Pharmacopoeia. Suppl. General Chapter 2.9.25: Chewing Gum, Medicated Release from. 3rd Ed. Strasbourg, France; European Directorate for the Quality of Medicines, Council of Europe; 2000:104.
9. European Directorate for the Quality of Medicines, Council of Europe. European Pharmacopoeia. Suppl. 5.2. General Monograph 2.9.25: Dissolution Test for Medicated Chewing Gums. 5th Ed. Strasbourg, France; 2005:3116-3117.
10. European Directorate for the Quality of Medicines, Council of Europe. European Pharmacopoeia. General Monograph 2.9.25: Dissolution Test for Medicated Chewing Gums. 6th Ed. Strasbourg, France; 2008:304-306.
11. Rassing MR. Chewing gum as a drug delivery system. Adv Drug Deliv Rev. 1994; 13:89-121.
12. Morjaria Y, Irwin WJ, Barnett PX, Chan RS, Conway BR. In vitro release of nicotine from chewing gum formulations. Dissolution Technol. 2004;11(2):12-15.
13. Siewert M, Dressman JB, Brown C, Shah VP. FIP/AAPS guidelines for dissolution/in vitro release testing of novel/special dosage forms. Dissolution Technol. 2003;2:6-15.
14. Möller H, Shah V, Brown C. Dissolution testing of special dosage forms. Dissolution Technol. 1999;6(4):18-20.
15. Yang X, Wang G, Zhang X. Release kinetics of catechins from chewing gum. J Pharm Sci. 2004;93(2):293-299.
16. Jensen E, Lokind KB, Pedersen K Rassing MR. Chewing gum as a drug delivery system-influence of additives upon the rate of drug release of metronidazole and propranolol hydrochloride from chewing gum. Farmaci Sci Ed. 1988;16:94-97.
17. Christrup LL, Moeller N. Chewing gum as a drug delivery system I. in vitro simulation of human mastication and influence of formulation upon the release of a water-soluble drug. Arch Pharnt Chem Sci Ed. 1996;14:30-36.
18. Christrup LL, Rassing MR. Chewing gum as a drug delivery system: influence of the formulation upon the rate of release of salicylamide. Farmaci Sci Ed. 1988;16:1-5.
19. Faraj JA, Dorati R, Schoubben A, et al. Development of a peptide-containing chewing gum as a sustained release antiplaque antimicrobial delivery system. AAPS Pharm Sci Tech. 2007;8(1):26.
20. Pedersen M, Rassing MR. Miconazole and miconazolenitrate chewing gum as drug delivery systems: a practical approach of solid dispersion technique. Drug Dev Ind Pharm. 1990;16(1):55-74.
21. Pedersen M, Rassing MR. Miconazole chewing gum as a drug delivery system test of release promoting additives. Drug Dev Ind Pharm. 1991;17(3):411-420.
22. Kvist C, Andersson SB, Fors S, Wennergren B, Berglund J. Apparatus for studying in vitro drug release from medicated chewing gums. Int J Pharm. 1999;189(1):57-65.
23. Kvist LC, Andersson SB, Berglund J, Wennergren B, Fors, SM. Equipment for drug release testing of medicated chewing gums. J Pharm Biomed Anal. 2000;22(3):405-411.
24. Andersen T, Gram-Hansen M, Pedersen M, Rassing MR. Chewing gum as a drug delivery system for nystatin-influence of Solubilizing agents upon the release of water insoluble drugs. Drug Dev Ind Pharm. 1990;16(13):1985-1994.
25. Jensen LN, Christrup LL, Menger N, Bundgaard H. Chewing gum and lozenges as delivery systems for noscapine. Acta Pharm Nord. 1991;3(4):219-222.